SPPAM
KMTS

Summit Partners Public Asset Management’s Kestra Medical Technologies KMTS Stock Holding History

Summit Partners Public Asset Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-147,273
Closed -$2.94M – 232
2026
Q1 		$2.94M Sell
147,273
-202,727
-58% -$4.78M 0.08% 133
2025
Q4 		$9.28M Buy
+350,000
New +$9.01M 0.19% 92

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Summit Partners Public Asset Management's KMTS Position: Q2 2026 in Review

Summit Partners Public Asset Management sold out of Kestra Medical Technologies (KMTS) in Q2 2026, closing a stake of 147,273 shares — an estimated $2.94M sold.

Summit Partners Public Asset Management first reported a position in KMTS in Q4 2025 and held it in 2 quarters. The position peaked at $9.28M in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Summit Partners Public Asset Management reported no remaining Kestra Medical Technologies position as of Q2 2026 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 147,273 Kestra Medical Technologies shares in Q2 2026, an estimated $2.94M.
  • Summit Partners Public Asset Management first reported a position in Kestra Medical Technologies in Q4 2025 and held it in 2 quarters.
  • Summit Partners Public Asset Management's Kestra Medical Technologies position peaked at $9.28M in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.